Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mallinckrodt Plc Ordinary Share (MNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,061,500
  • Shares Outstanding, K 95,000
  • Annual Sales, $ 829,900 K
  • Annual Income, $ -153,200 K
  • 36-Month Beta 1.30
  • Price/Sales 0.69
  • Price/Cash Flow 88.43
  • Price/Book 0.43

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.00 +0.48%
on 01/18/18
24.80 -14.92%
on 12/26/17
-2.01 (-8.70%)
since 12/19/17
3-Month
19.00 +11.05%
on 11/08/17
32.87 -35.81%
on 10/20/17
-11.72 (-35.71%)
since 10/19/17
52-Week
19.00 +11.05%
on 11/08/17
55.32 -61.86%
on 02/22/17
-27.02 (-56.15%)
since 01/19/17

Most Recent Stories

More News
Mallinckrodt Down 36.1% Since SmarTrend Downtrend Call (MNK)

SmarTrend identified a Downtrend for Mallinckrodt (NYSE:MNK) on October 13th, 2017 at $33.96. In approximately 3 months, Mallinckrodt has returned 36.10% as of today's recent price of $21.70.

MNK : 21.14 (-2.58%)
Walmart offers way to turn leftover opioids into useless gel

Walmart is helping customers get rid of leftover opioids by giving them packets that turn the addictive painkillers into a useless gel.

MNK : 21.14 (-2.58%)
Endo (ENDP) Loses 35% in a Year: Can It Turn Around in 2018?

Endo International (ENDP) lost 35% in the past year mired by controversy related to Opana ER and weaknesses in both the businesses.

ENDP : 7.00 (-4.76%)
SCMP : 17.98 (+0.17%)
EXEL : 27.77 (-0.32%)
MNK : 21.14 (-2.58%)
Endo (ENDP) Gets Subpoena From Florida for Opioid Misuse

Endo (ENDP) announced that it received a subpoena from the Florida authorities in connection with products related to opioid misuse.

ENDP : 7.00 (-4.76%)
SCMP : 17.98 (+0.17%)
EXEL : 27.77 (-0.32%)
MNK : 21.14 (-2.58%)
32.2% Return Seen to Date on SmarTrend Mallinckrodt Call (MNK)

SmarTrend identified a Downtrend for Mallinckrodt (NYSE:MNK) on October 13th, 2017 at $33.96. In approximately 3 months, Mallinckrodt has returned 32.24% as of today's recent price of $23.01.

MNK : 21.14 (-2.58%)
Blog Exposure - Baxter International Acquires RECOTHROM and PREVELEAK from Mallinckrodt

Stock Monitor: Mallinckrodt Post Earnings Reporting

BAX : 69.82 (+0.90%)
MNK : 21.14 (-2.58%)
Mallinckrodt (MNK) to Sell Recothrom and Preveleak to Baxter

Mallinckrodt's (MNK) strategy to streamline its business to evolve as a top-performing specialty pharmaceutical company has led the company to enter into an agreement to sell Recothrom and Preveleak to...

SCMP : 17.98 (+0.17%)
MDCO : 24.72 (-1.24%)
BAX : 69.82 (+0.90%)
MNK : 21.14 (-2.58%)
Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter

Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, announced today it has entered into an agreement under which it will sell certain hemostasis products to Baxter International Inc....

BAX : 69.82 (+0.90%)
MNK : 21.14 (-2.58%)
Mallinckrodt Completes Stannsoporfin New Drug Application Filing

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has successfully completed the rolling submission of a New Drug Application (NDA) to the U.S. Food and...

MNK : 21.14 (-2.58%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

SCMP : 17.98 (+0.17%)
MNK : 21.14 (-2.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media...

See More

Key Turning Points

2nd Resistance Point 22.93
1st Resistance Point 22.31
Last Price 21.14
1st Support Level 21.04
2nd Support Level 20.39

See More

52-Week High 55.32
Fibonacci 61.8% 41.45
Fibonacci 50% 37.16
Fibonacci 38.2% 32.87
Last Price 21.14
52-Week Low 19.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.